Skip to main navigation Skip to search Skip to main content

The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors

  • L. Nathan Tumey
  • , David Bom
  • , Bayard Huck
  • , Elizabeth Gleason
  • , Jianmin Wang
  • , Daniel Silver
  • , Kurt Brunden
  • , Sherry Boozer
  • , Stephen Rundlett
  • , Bruce Sherf
  • , Steven Murphy
  • , Tom Dent
  • , Christina Leventhal
  • , Andrew Bailey
  • , John Harrington
  • , Youssef L. Bennani
  • Athersys Ltd

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Abstract

We describe the identification and SAR of a series of low nanomolar inhibitors of FEN1, an enzyme involved in DNA repair pathways. These inhibitors have been shown to sensitize certain cell lines to DNA damage. Flap endonuclease-1 (FEN1) is a key enzyme involved in base excision repair (BER), a primary pathway utilized by mammalian cells to repair DNA damage. Sensitization to DNA damaging agents is a potential method for the improvement of the therapeutic window of traditional chemotherapeutics. In this paper, we describe the identification and SAR of a series of low nanomolar FEN1 inhibitors. Over 1000-fold specificity was achieved against a related endonuclease, xeroderma pigmentosum G (XPG). Two compounds from this series significantly potentiate the action of methyl methanesulfonate (MMS) and temozolamide in a bladder cancer cell line (T24). To our knowledge, these are the most potent endonuclease inhibitors reported to date.

Original languageEnglish
Pages (from-to)277-281
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume15
Issue number2
DOIs
StatePublished - Jan 17 2005

Keywords

  • Cancer
  • DNA repair
  • Endonuclease
  • FEN1

Fingerprint

Dive into the research topics of 'The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors'. Together they form a unique fingerprint.

Cite this